Revenue | ₹167.41Cr |
Net Profits | ₹6.00Cr |
Net Profit Margins | 3.58% |
Fredun Pharmaceuticals Ltd’s revenue jumped 41.84% since last year same period to ₹167.41Cr in the Q4 2024-2025. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated 63.01% jump in its revenue since last 3-months.
Fredun Pharmaceuticals Ltd’s net profit jumped 18.58% since last year same period to ₹6.00Cr in the Q4 2024-2025. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated 12.57% jump in its net profits since last 3-months.
Fredun Pharmaceuticals Ltd’s net profit margin fell -16.4% since last year same period to 3.58% in the Q4 2024-2025. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated -30.94% fall in its net profit margins since last 3-months.
The revenue for Fredun Pharmaceuticals Ltd in the Q4 results 2024 was ₹167.41Cr.
The net profit for Fredun Pharmaceuticals Ltd in the Q4 results 2024 was ₹6.00Cr.
The net profit margin for Fredun Pharmaceuticals Ltd in the Q4 results 2024 was 3.58%.
The revenue for Fredun Pharmaceuticals Ltd in the Q4 results 2023 was ₹118.03Cr.
The net profit for Fredun Pharmaceuticals Ltd in the Q4 results 2023 was ₹5.06Cr.
The net profit margin for Fredun Pharmaceuticals Ltd in the Q4 results 2023 was 4.29%.